pharma · Melanoma · Multiple Myeloma · RNA
Atrium Therapeutics
Atrium Therapeutics clinical programs — 31 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 10578 Science Center Dr, Suite 125, San Diego, California 92121, US
- Founded
- 2026
- Employees
- 46
- Programs
- 31
- Drugs
- 33
- Patents
- 37
Atrium Therapeutics projects
31 ClinicalTrials.gov programs sponsored by Atrium Therapeutics.
Atrium Therapeutics has 31 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
PGET
Atrium Therapeutics
Osteoarthritis
1 trial -
Phlebotomy
Atrium Therapeutics
Hemochromatosis
1 trial -
Phlebotomy and erythrocytapheresis
Atrium Therapeutics
Hereditary Hemochromatosis
1 trial -
Ropivacaine HCL
Atrium Therapeutics
Renal Carcinoma
1 trial -
Wobenzym® N
Atrium Therapeutics
Knee Osteoarthritis
1 trial -
eythrocytapheresis
Atrium Therapeutics
Pre Operative Autologous Donation
1 trial -
Carboplatin
Atrium Therapeutics
Lung Cancer Stage II
1 trial -
Diclofenac
Atrium Therapeutics
Wobenzym
1 trial -
Elotuzumab
Atrium Therapeutics
Multiple Myeloma
1 trial -
Low-dose ASA
Atrium Therapeutics
Germ Cell Tumor
1 trial -
Metformin Hydrochloride ER
Atrium Therapeutics
Sarcoma Metastatic
1 trial -
Nivolumab
Atrium Therapeutics
Multiple Myeloma
1 trial -
Olutasidenib
Atrium Therapeutics
IDH1 Mutation
1 trial -
Vaccine
Atrium Therapeutics
Pediatric Cancer
1 trial -
anastrozole
Atrium Therapeutics
Female Breast Carcinoma
1 trial -
IVAC MUTANOME, RBL001/RBL002
Atrium Therapeutics
Melanoma
1 trial -
Nivolumab
Atrium Therapeutics
Brain and Nervous System
1 trial -
Novel Supplement Based Therapy
Atrium Therapeutics
Small Intestinal Bacterial Overgrowth
1 trial -
RBL001/RBL002
Atrium Therapeutics
Melanoma
1 trial -
SAR441000
Atrium Therapeutics
Metastatic Neoplasm
1 trial -
Phenoxybenzamine
Atrium Therapeutics
Pheochromocytoma
1 trial -
Rivastigmine
Atrium Therapeutics
Parkinson's Disease
1 trial -
Abciximab local infusion
Atrium Therapeutics
Acute Anterior Myocardial Infarction
1 trial -
Cranberry
Atrium Therapeutics
Endotoxemia
1 trial -
High Dose Vitamin D
Atrium Therapeutics
Breast
1 trial -
NO Ultra
Atrium Therapeutics
Hypertension
1 trial -
Orthica Soft Multi Mini and Orthica Fish EPA Mini
Atrium Therapeutics
Psychiatric Hospitalization
1 trial -
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Atrium Therapeutics
Cancer
1 trial -
Polyphenol-rich extract
Atrium Therapeutics
Healthy Elderly
1 trial -
Resveratrol, curcumin
Atrium Therapeutics
Effect of Resveratrol and Curcumin on Inflammation
1 trial -
Wobenzym PS
Atrium Therapeutics
Sub-clinical Inflammation
1 trial
Frequently asked questions
How many clinical projects does Atrium Therapeutics have?
31 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.